• Don’t Let The High Cost Of Prescription Drugs Cost You Your Health (Washington, DC) – For older Americans, the high cost of prescription drugs is a leading deterrent to filling prescriptions or taking required medications as directed, warns The Senior Citizens League.  “People with Medicare coverage should take time now during the Medicare Fall Open Enrollment period to learn about the changes in their Medicare drug coverage ...
  • Benefit Bulletin: November 2017 Despite Support, No Bill Moving On Medicare Drug Price Negotiations Ninety percent of the people participating in TSCL’s 2017 Senior Survey support giving Medicare the power to negotiate lower drug prices. But so far, Congress has taken no action on a number of bills introduced earlier this year. Current law specifically forbids Medicare from negotiating with drug ...
  • Benefit Bulletin: August 2017 Drug Rebates Often Not Going To Patients A behind-the-scene rebate game between drug makers, health insurers and their pharmacy benefit managers is costing you and the Medicare program in higher drug costs.  A research paper published by JAMA Internal Medicine finds that prescription drug rebates, which are received by health plans and pharmacy benefit managers, may ...
  • Retiree Testifies Costs For One Drug Went From $700 To $10,000 Sudden price spikes in older drugs are putting patients at risk of going without vital medicine.  A new report by the U.S. Senate Special Committee on Aging uncovered an insidious business model that’s leading to monopoly pricing power and astronomical price increases. Berna Heyman, a retired librarian who has Wilson Disease testified how she was a ...
  • Benefit Bulletin: February/March 2017 What a New Congress Means For Medicare TSCL is closely following proposals that would overhaul Medicare as a part of the plans to repeal the 2010 Affordable Care Act.  House Speaker Paul Ryan (WI) has put forward a plan to modernize Medicare by phasing out Medicare as we now know it. Ryan’s plan would make the ...
  • What’s A Medicare “Buy-In”? In the debate over rising healthcare costs, attention has focused on people age 50 to 64 who are among those with the highest premiums, deductibles, and out-of-pocket  costs.  Some policy experts say that removing these older people from the market for younger workers would lower costs, and proponents of the idea argue that people age ...
  • High Drug Prices A Major Issue For The Next Congress The EpiPen, the latest example in extreme drug price hikes, has not only led to Congressional hearings and outrage over price gouging, but is raising new questions as to why so many older adults are getting prescriptions for the drug in the first place.  At the same time the cost of the EpiPen dramatically increased ...
  • Medicare Proposes Tying Drug Costs to Effectiveness The Centers for Medicare and Medicaid Services (CMS) recently announced plans to test new ways to rein in costs of some of the nation’s most expensive drugs, like cancer and rheumatoid arthritis treatments, that are administered in doctors’ offices and outpatient centers.  The current Medicare Part B payment system, officials argue, provides incentives for prescribing ...
  • Drug Pricing Abuse Comes Under New Scrutiny The drug industry’s secretive pricing practices are coming under increasing scrutiny in Congress. According to a recent poll, the public thinks making sure that high-cost drugs for chronic conditions are affordable to those who need them is a top priority for Congress and the President. Government action to lower prescription drug costs ranks second. But ...
  • Retirees Worry Over Spiking Drug Costs, Says The Senior Citizens League (Washington, DC) – Anxiety of older Americans over steep cost increases of prescription drugs is at the highest level since the start of Medicare Part D a decade ago, according to The Senior Citizens League (TSCL). Since last fall, TSCL has been collecting comments from older adults on how they are coping with rapidly rising ...
Print Friendly

Close